As we head towards the third committee meeting for the efgartigimod appraisal process, which will see whether or not the drug gains positive guidance for use through the NHS, myaware and MDUK wished to outline the reality for myasthenia patients in this country and why targeted therapeutics could make such a positive impact on their lives. 

Read our letter

If you agree with our statement, we have prepared this letter as a petition on We welcome any signatories from our communities so that when this page is presented to NICE, they appreciate the scale of agreement and how many this statement resonates with.